BI 54903/tiotropium bromide

Drug Profile

BI 54903/tiotropium bromide

Alternative Names: Tiotropium bromide/BI 54903

Latest Information Update: 17 Mar 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Boehringer Ingelheim
  • Class Antiasthmatics; Antibronchitics; Small molecules; Tropanes
  • Mechanism of Action Muscarinic M1 receptor antagonists; Muscarinic M3 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Asthma; Respiratory tract disorders

Most Recent Events

  • 16 Mar 2017 Discontinued - Phase-I for Respiratory tract disorders (In volunteers) in Germany before March 2017 (Inhalation)
  • 16 Mar 2017 Discontinued - Phase-II for Asthma in Slovakia before March 2017 (Inhalation)
  • 16 Jul 2016 No recent reports of development identified for phase-I development in Respiratory-tract-disorders(In volunteers) in Germany (Inhalation, Powder)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top